Mutagenicity tests of 4-phenyl-1,3-dithia-2-thioxo-cyclopent-4-ene

Area of Science:

• Toxicology
• Genetics
• Chemical Safety

Background:

• Assessing the genotoxic potential of novel chemical compounds is crucial for risk assessment.
• 4-phenyl-1,3-dithia-2-thioxo-cyclopent-4-ene (DT827B) is a compound requiring evaluation for mutagenic and clastogenic effects.

Purpose of the Study:

• To evaluate the mutagenicity and genotoxicity of DT827B using a battery of standard in vitro and in vivo assays.
• To determine if DT827B induces gene mutations, chromosomal aberrations, or micronuclei formation.

Main Methods:

• Bacterial reverse mutation assay (Ames test) using Salmonella typhimurium and Escherichia coli.
• In vitro chromosomal aberration test using Chinese hamster ovary (CHO) cells.
• In vivo micronucleus test using mouse bone marrow cells.

Main Results:

• DT827B was not mutagenic to S. typhimurium or E. coli up to its solubility limit.
• DT827B did not induce structural chromosomal aberrations in CHO cells but did induce polyploidy.
• DT827B did not induce micronuclei formation in mouse bone marrow cells at the maximum dose.

Conclusions:

• DT827B is considered non-mutagenic in bacterial systems and non-clastogenic in mammalian cells under the tested conditions.
• The observed polyploidy induction in CHO cells is likely a consequence of DT827B's cytotoxic effects rather than direct genotoxicity.
• Further investigation into the toxicological profile of DT827B may be warranted.